Cost-effectiveness of norovirus vaccination in children in Peru

Vaccine

Volumn 33, Issue 27, 2015, Pages 3084-3091

  Mirelman, Andrew J ^a   Ballard, Sarah Blythe ^b   Saito, Mayuko ^c,d   Kosek, Margaret N ^b   Gilman, Robert H ^b,e  

^a UNIVERSITY OF YORK   (United Kingdom)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d ASOCIACIÓN BENÉFICA PRISMA   (Peru)

^e UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Caliciviruses; Cost effectiveness; Diarrhea; Gastroenteritis; LMIC; Norovirus; Peru; Vaccine

Indexed keywords

NOROVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ARTICLE; BIRTH; CHILD; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DRUG EFFICACY; GROSS NATIONAL PRODUCT; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; NEWBORN; NOROVIRUS INFECTION; OUTPATIENT; PERU; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VACCINATION; CALICIVIRIDAE INFECTIONS; COHORT ANALYSIS; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; ECONOMICS; GASTROENTERITIS; IMMUNOLOGY; NOROVIRUS; PRESCHOOL CHILD; PROCEDURES;

CALICIVIRIDAE INFECTIONS; CHILD, PRESCHOOL; COHORT STUDIES; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; GASTROENTERITIS; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; NOROVIRUS; PERU; VACCINATION; VIRAL VACCINES;

EID: 84937637600     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.05.004     Document Type: Article

References (35)

1. Liu L., Oza S., Hogan D., Perin J., Rudan I., Lawn J.E., et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 2014, 385(9966):430-440.
2. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003, 9:565-572.
3. Fischer Walker C.L., Perin J., Aryee M.J., Boschi-Pinto C., Black R.E. Diarrhea incidence in low- and middle-income countries in 1990 and 2010: a systematic review. BMC Public Health 2012, 12:220.
4. The World Factbook-CIA The World Factbook-CIA 2013, (Accessed 14 May 2015).
5. World Health Organization WHO vaccine-preventable diseases: monitoring system. 2014 global summary. WHO-UNICEF Joint Reporting Forum and WHO regional offices 2014, http://appswhoint/immunization_monitoring/globalsummary/countries?countrycriteria[country][]=PER&commit=OK (accessed 29 December 2014).
6. Saito M., Goel-Apaza S., Espetia S., Velasquez D., Cabrera L., Loli S., et al. Multiple norovirus infections in a birth cohort in a Peruvian peri-urban community. Clin Infect Dis 2013, 58(4):483-491. (an official publication of the Infectious Diseases Society of America).
7. Rapoport L.B., Mirelman A.J., Tejada Santiesteban M.G., Rafael Cordova B.M., Figueroa Quintanilla D.A., Gilman R.H., Ballard S.B. Food insecurity and indirect costs of medically attended gastroenteritis in children younger than five years of age in a post-rotavirus setting. 63rd annual meeting of the American Society of Tropical Medicine and Hygiene 2014.
8. Payne D.C., Vinje J., Szilagyi P.G., Edwards K.M., Staat M.A., Weinberg G.A., et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med 2013, 368:1121-1130.
9. Atmar R.L., Bernstein D.I., Harro C.D., Al-Ibrahim M.S., Chen W.H., Ferreira J., et al. Norovirus vaccine against experimental human Norwalk virus illness. N Engl J Med 2011, 365:2178-2187.
10. Debbink K., Lindesmith L.C., Baric R.S. The state of norovirus vaccines. Clin Infect Dis 2014, 58:1746-1752.
11. Vesikari T., Blazevic V. Norovirus vaccine one step closer. J Infect Dis 2014, 211(6):853-855.
12. Bartsch S.M., Lopman B.A., Hall A.J., Parashar U.D., Lee B.Y. The potential economic value of a human norovirus vaccine for the United States. Vaccine 2012, 30:7097-7104.
13. Bartsch S.M., Lee B.Y. Economics and financing of vaccines for diarrheal diseases. Hum Vaccin Immunother 2014, 10:1568-1581.
14. TreeAge Pro 2014, R2.1 TreeAge software 2015, MA.Software, Williamstown, available at: http://www.treeage.com (Accessed 14 May 2015).
15. Yori P.P., Lee G., Olortegui M.P., Chavez C.B., Flores J.T., Vasquez A.O., et al. Santa Clara de Nanay: the MAL-ED cohort in Peru. Clin Infect Dis 2014, 59(Suppl. 4):S310-S316. (an official publication of the Infectious Diseases Society of America).
16. The MAL-ED study The MAL-ED study: a multinational and multidisciplinary approach to understand the relationship between enteric pathogens, malnutrition, gut physiology, physical growth, cognitive development, and immune responses in infants and children up to 2 years of age in resource-poor environments. Clin Infect Dis 2014, 59(Suppl. 4):S193-S196. (an official publication of the Infectious Diseases Society of America).
17. Richard S.A., Barrett L.J., Guerrant R.L., Checkley W., Miller M.A. Disease surveillance methods used in the 8-site MAL-ED cohort study. Clin Infect Dis 2014, 59(Suppl. 4):S220-S224. (an official publication of the Infectious Diseases Society of America).
18. Ehrenkranz P., Lanata C.F., Penny M.E., Salazar-Lindo E., Glass R.I. Rotavirus diarrhea disease burden in Peru: the need for a rotavirus vaccine and its potential cost savings. Revista panamericana de salud publica 2001, 10:240-248.
19. Peru Demographic and Health Surveys, 2013 Peru demographic and health surveys, 2013-Final report continuous 2013, http://dhsprogram.com/publications/publication-FR299-DHS-Final-Reports.cfm (Accessed 14 May 2015).
20. Lamberti L.M., Fischer Walker C.L., Black R.E. Systematic review of diarrhea duration and severity in children and adults in low- and middle-income countries. BMC Public Health 2012, 12:276.
21. Wikswo M.E., Desai R., Edwards K.M., Staat M.A., Szilagyi P.G., Weinberg G.A., et al. Clinical profile of children with norovirus disease in rotavirus vaccine era. Emerg Infect Dis 2013, 19:1691-1693.
22. Lanata C.F., Fischer-Walker C.L., Olascoaga A.C., Torres C.X., Aryee M.J., Black R.E. Global causes of diarrheal disease mortality in children <5 years of age: a systematic review. PLoS ONE 2013, 8:e72788.
23. Clark A.D., Walker D.G., Mosqueira N.R., Penny M.E., Lanata C.F., Fox-Rushby J., et al. Cost-effectiveness of rotavirus vaccination in peru. J Infect Dis 2009, 200(Suppl. 1):S114-S124.
24. The World Bank The World Bank. Peru overview 2015, http://www.worldbank.org/en/country/peru/overview (Accessed 14 May 2015).
25. World Population Prospects World population prospects: the 2012 revision 2014, URL: http://esa.un.org/wpp/unpp/panel_population.htm (Accessed 14 May 2015).
26. PAHO PAHO Expanded program of immunization vaccine prices for year 2015. PAHO 2015, https://www.google.com.pe/search?q=Expanded+program+of+immunization+vaccine+prices+for+year+2015%2C+PAHO+2015&oq=Expanded+program+of+immunization+vaccine+prices+for+year+2015%2C+PAHO+2015&aqs=chrome.69i57j69i60.12571848j0j7&sourceid=chrome&es_sm=91&ie=UTF-8.
27. Novaes H.M., e Silva G.A., Itria A., Rama C.H., Sartori A.M., de Soarez P.C., et al. Introduction of universal human papillomavirus vaccination of girls aged 11 years to the National Immunization Program in Brazil. Vaccine 2015, 33S:A135-A142.
28. World Health Organization Choosing interventions that are cost-effective 2014, URL: http://www.who.int/choice/costs/CER_thresholds/en/ (Accessed 14 May 2015).
29. The World Bank Data: GDP per capita 2015, URL: http://data.worldbank.org/indicator/NY.GDP.PCAP.CD (Accessed 14 May 2015).
30. Hird T.R., Grassly N.C. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog 2012, 8:e1002599.
31. Kotloff K.L., Nataro J.P., Blackwelder W.C., Nasrin D., Farag T.H., Panchalingam S., et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013, 382:209-222.
32. O'Ryan M.L., Pena A., Vergara R., Diaz J., Mamani N., Cortes H., et al. Prospective characterization of norovirus compared with rotavirus acute diarrhea episodes in Chilean children. Pediatr Infect Dis J 2010, 29:855-859.
33. Cama R.I., Parashar U.D., Taylor D.N., Hickey T., Figueroa D., Ortega Y.R., et al. Enteropathogens and other factors associated with severe disease in children with acute watery diarrhea in Lima, Peru. J Infect Dis 1999, 179:1139-1144.
34. Parashar U.D., Li J.F., Cama R., DeZalia M., Monroe S.S., Taylor D.N., et al. Human caliciviruses as a cause of severe gastroenteritis in Peruvian children. J Infect Dis 2004, 190:1088-1092.
35. McCabe C., Claxton K., Culyer A.J. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics 2008, 26:733-744.